Items where Author is "Schimmelmann, B. G."

2016

Hochstrasser, L. and Borgwardt, S. and Lambert, M. and Schimmelmann, B. G. and Lang, U. and Stieglitz, R. -D. and Huber, C. G.. (2016) Association of Positive and Negative Syndrome Scale short forms with global functioning and quality of life. Acta Psychiatrica Scandinavica, 134 (6). pp. 563-564.

2015

Schmidt, S. J. and Schultze-Lutter, F. and Schimmelmann, B. G. and Maric, N. P. and Salokangas, R. K. R. and Riecher-Rössler, A. and van der Gaag, M. and Meneghelli, A. and Nordentoft, M. and Marshall, M. and Morrison, A. and Raballo, A. and Klosterkötter, J. and Ruhrmann, S.. (2015) EPA guidance on the early intervention in clinical high risk states of psychoses. European Psychiatry, 30 (3). pp. 388-404.

2014

Jarick, I. and Volckmar, A. L. and Pütter, C. and Pechlivanis, S. and Nguyen, T. T. and Dauvermann, M. R. and Beck, S. and Albayrak, Ö. and Scherag, S. and Gilsbach, S. and Cichon, S. and Hoffmann, P. and Degenhardt, F. and Nöthen, M. M. and Schreiber, S. and Wichmann, H.-E. and Jöckel, K.-H. and Heinrich, J. and Tiesler, C. M. T. and Faraone, S. V. and Walitza, S. and Sinzig, J. and Freitag, C. and Meyer, J. and Herpertz-Dahlmann, B. and Lehmkuhl, G. and Renner, T. J. and Warnke, A. and Romanos, M. and Lesch, K.-P. and Reif, A. and Schimmelmann, B. G. and Hebebrand, J. and Scherag, A. and Hinney, A.. (2014) Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder. Molecular Psychiatry, 19 (1). pp. 115-121.